BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 30307405)

  • 1. Effects of selected triorganotin compounds on transcriptional activity of vitamin D3 receptor and peroxisome proliferator-activated receptor gamma.
    Toporova L; Illes P; Dvorak Z; Bobal P; Otevrel J; Brtko J
    Gen Physiol Biophys; 2018 Sep; 37(5):589-596. PubMed ID: 30307405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Crosstalk between the peroxisome proliferator-activated receptor γ (PPARγ) and the vitamin D receptor (VDR) in human breast cancer cells: PPARγ binds to VDR and inhibits 1α,25-dihydroxyvitamin D3 mediated transactivation.
    Alimirah F; Peng X; Yuan L; Mehta RR; von Knethen A; Choubey D; Mehta RG
    Exp Cell Res; 2012 Nov; 318(19):2490-7. PubMed ID: 22884583
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of Flavored Nonalcoholic Beverages on Transcriptional Activities of Nuclear and Steroid Hormone Receptors: Proof of Concept for Novel Reporter Cell Line PAZ-PPARg.
    Illés P; Grycová A; Krasulová K; Dvořák Z
    J Agric Food Chem; 2018 Nov; 66(45):12066-12078. PubMed ID: 30394742
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of human interleukins in the transgenic gene reporter cell lines IZ-VDRE and IZ-CYP24 designed to assess the transcriptional activity of vitamin D receptor.
    Bartonkova I; Kallay E; Dvorak Z
    PLoS One; 2018; 13(2):e0193655. PubMed ID: 29489902
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Organotin compounds cause structure-dependent induction of progesterone in human choriocarcinoma Jar cells.
    Hiromori Y; Yui H; Nishikawa J; Nagase H; Nakanishi T
    J Steroid Biochem Mol Biol; 2016 Jan; 155(Pt B):190-8. PubMed ID: 25465476
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cross-talk between vitamin D receptor (VDR)- and peroxisome proliferator-activated receptor (PPAR)-signaling in melanoma cells.
    Sertznig P; Dunlop T; Seifert M; Tilgen W; Reichrath J
    Anticancer Res; 2009 Sep; 29(9):3647-58. PubMed ID: 19667161
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fine tuning of agonistic/antagonistic activity for vitamin D receptor by 22-alkyl chain length of ligands: 22S-Hexyl compound unexpectedly restored agonistic activity.
    Anami Y; Sakamaki Y; Itoh T; Inaba Y; Nakabayashi M; Ikura T; Ito N; Yamamoto K
    Bioorg Med Chem; 2015 Nov; 23(22):7274-81. PubMed ID: 26515040
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The human peroxisome proliferator-activated receptor delta gene is a primary target of 1alpha,25-dihydroxyvitamin D3 and its nuclear receptor.
    Dunlop TW; Väisänen S; Frank C; Molnár F; Sinkkonen L; Carlberg C
    J Mol Biol; 2005 Jun; 349(2):248-60. PubMed ID: 15890193
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular mechanism of 1,25-dihydroxyvitamin D3 inhibition of adipogenesis in 3T3-L1 cells.
    Kong J; Li YC
    Am J Physiol Endocrinol Metab; 2006 May; 290(5):E916-24. PubMed ID: 16368784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Profiling of Vitamin D Metabolic Intermediates toward VDR Using Novel Stable Gene Reporter Cell Lines IZ-VDRE and IZ-CYP24.
    Bartonkova I; Grycova A; Dvorak Z
    Chem Res Toxicol; 2016 Jul; 29(7):1211-22. PubMed ID: 27327272
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural basis for PPARγ transactivation by endocrine-disrupting organotin compounds.
    Harada S; Hiromori Y; Nakamura S; Kawahara K; Fukakusa S; Maruno T; Noda M; Uchiyama S; Fukui K; Nishikawa J; Nagase H; Kobayashi Y; Yoshida T; Ohkubo T; Nakanishi T
    Sci Rep; 2015 Feb; 5():8520. PubMed ID: 25687586
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methyl donor deficiency impairs bone development via peroxisome proliferator-activated receptor-γ coactivator-1α-dependent vitamin D receptor pathway.
    Feigerlova E; Demarquet L; Melhem H; Ghemrawi R; Battaglia-Hsu SF; Ewu E; Alberto JM; Helle D; Weryha G; Guéant JL
    FASEB J; 2016 Oct; 30(10):3598-3612. PubMed ID: 27435264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rational screening of peroxisome proliferator-activated receptor-γ agonists from natural products: potential therapeutics for heart failure.
    Chen R; Wan J; Song J; Qian Y; Liu Y; Gu S
    Pharm Biol; 2017 Dec; 55(1):503-509. PubMed ID: 27937122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Triorganotin compounds--ligands for "rexinoid" inducible transcription factors: biological effects.
    Brtko J; Dvorak Z
    Toxicol Lett; 2015 Apr; 234(1):50-8. PubMed ID: 25683035
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vitamin D receptor, Retinoid X receptor and peroxisome proliferator-activated receptor γ are overexpressed in BRCA1 mutated breast cancer and predict prognosis.
    Heublein S; Mayr D; Meindl A; Kircher A; Jeschke U; Ditsch N
    J Exp Clin Cancer Res; 2017 Apr; 36(1):57. PubMed ID: 28427429
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Organotin compounds promote adipocyte differentiation as agonists of the peroxisome proliferator-activated receptor gamma/retinoid X receptor pathway.
    Kanayama T; Kobayashi N; Mamiya S; Nakanishi T; Nishikawa J
    Mol Pharmacol; 2005 Mar; 67(3):766-74. PubMed ID: 15611480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Absence of vitamin D receptor (VDR)-mediated PPARγ suppression causes alopecia in VDR-null mice.
    Saini V; Zhao H; Petit ET; Gori F; Demay MB
    FASEB J; 2017 Mar; 31(3):1059-1066. PubMed ID: 27932380
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 15-Deoxy-Delta12,14-prostaglandin J2 enhances docetaxel anti-tumor activity against A549 and H460 non-small-cell lung cancer cell lines and xenograft tumors.
    Fulzele SV; Chatterjee A; Shaik MS; Jackson T; Ichite N; Singh M
    Anticancer Drugs; 2007 Jan; 18(1):65-78. PubMed ID: 17159504
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction of two novel 14-epivitamin D3 analogs with vitamin D3 receptor-retinoid X receptor heterodimers on vitamin D3 responsive elements.
    Verlinden L; Verstuyf A; Quack M; Van Camp M; Van Etten E; De Clercq P; Vandewalle M; Carlberg C; Bouillon R
    J Bone Miner Res; 2001 Apr; 16(4):625-38. PubMed ID: 11315990
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endocrine-disrupting organotin compounds are potent inducers of adipogenesis in vertebrates.
    Grün F; Watanabe H; Zamanian Z; Maeda L; Arima K; Cubacha R; Gardiner DM; Kanno J; Iguchi T; Blumberg B
    Mol Endocrinol; 2006 Sep; 20(9):2141-55. PubMed ID: 16613991
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.